Global Pharmas Casting Colder Eyes on Japan Market; PhRMA, EFPIA to Up Lobbying Efforts with Govt, Ruling Parties

March 11, 2016
A few years ago, Japan’s drug market was attracting massive foreign investments. While other major markets showed tepid growth, Japan introduced a price maintenance scheme for on-patent drugs and positive measures to reward innovation, prompting global mega pharmas to ramp...read more